ABSTRACT TOPICS

1. Safety of COVID-19 vaccines and therapies and their global introduction
2. Good Pharmacovigilance Practices and efforts of regulatory harmonization in PV
3. Engaging patient and communities in pharmacovigilance
4. Collaboration between stakeholders to improve pharmacovigilance systems. 
5. Vaccine safety surveillance and pharmacovigilance in Public Health Programmes
6. Harmonising safety surveillance across classes of health products 
7. Integrating safety data from different sources
8. Global vs regional and country perspectives in pharmacovigilance
9. New approaches to ensure the safe use of medicines. 
10. Benefits vs Risks of medicines in pregnancy
11. Promising use of new technologies and methods in pharmacovigilance
12. Risk Minimization interventions: systematic approaches to measure the impact of PV activities
13. Miscellaneous